Abstract | BACKGROUND: The purpose of this study was to assess the relationship between [(18) F]-fluorodeoxyglucose ((18) FDG)-positron emission tomography/CT ((18) FDG-PET/CT) and serum thyroglobulin (Tg) in patients with recurrent differentiated thyroid carcinoma (DTC). METHODS: Forty-two patients with recurrent DTC and negative Tg antibodies were included in the study. All patients underwent (131) I therapy due to an increasing serum Tg with a corresponding negative (131) I posttreatment whole body scan. The (18) FDG-PET/CT scans were then performed on all patients, serum Tg was measured concurrently, and respective results were compared. RESULTS: Sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV), and accuracy of the (18) FDG-PET/CT examination were 93%, 84%, 93%, 84%, and 90%, respectively. The sensitivity of (18) FDG-PET/CT significantly increased in patients with serum Tg levels ≥4.6 ng/mL (96%) in comparison with patients having lower levels (25%; p < .001). Nonetheless, 3 of 27 patients (11%) with a true-positive (18) FDG-PET/CT still had a Tg <4.6 ng/mL. CONCLUSION: Although (18) FDG-PET/CT scans are more likely to be positive with pretest Tg levels ≥4.6 ng/mL, 11% of patients with DTC with a lower serum Tg level will still have a positive scan. Our findings are in contrast with the American Thyroid Association (ATA) guidelines, which only recommend to perform (18) FDG-PET/CT in patients with Tg levels >10 ng/mL.
|
Authors | Luca Giovanella, Luca Ceriani, Diego De Palma, Sergio Suriano, Massimo Castellani, Frederik A Verburg |
Journal | Head & neck
(Head Neck)
Vol. 34
Issue 5
Pg. 626-31
(May 2012)
ISSN: 1097-0347 [Electronic] United States |
PMID | 21850699
(Publication Type: Journal Article)
|
Copyright | Copyright © 2011 Wiley Periodicals, Inc. |
Chemical References |
- Iodine Radioisotopes
- Radiopharmaceuticals
- Fluorodeoxyglucose F18
- Thyroglobulin
|
Topics |
- Adenocarcinoma, Follicular
(diagnostic imaging, therapy)
- Adult
- Aged
- Carcinoma, Papillary
(diagnostic imaging, therapy)
- Female
- Fluorodeoxyglucose F18
- Humans
- Iodine Radioisotopes
(therapeutic use)
- Lymphatic Metastasis
(diagnosis)
- Male
- Middle Aged
- Multimodal Imaging
- Neoplasm Recurrence, Local
(diagnosis)
- Positron-Emission Tomography
- Predictive Value of Tests
- ROC Curve
- Radiopharmaceuticals
- Sensitivity and Specificity
- Thyroglobulin
(blood)
- Thyroid Neoplasms
(diagnostic imaging, therapy)
- Tomography, X-Ray Computed
- Young Adult
|